{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T03:14:59Z","timestamp":1788318899555,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012423","name":"Children's Healthcare of Atlanta Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurophysiology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.clinph.2026.2112353","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T23:27:55Z","timestamp":1785194875000},"page":"2112353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Compound muscle action potential amplitudes in newborn screen positive spinal muscular atrophy"],"prefix":"10.1016","volume":"191","author":[{"given":"Bahadir M.","family":"Samur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekta Bery","family":"Salhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2841-1311","authenticated-orcid":false,"given":"Sneha","family":"Sadhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5077-4491","authenticated-orcid":false,"given":"Niharika","family":"Bheemisetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5852-8065","authenticated-orcid":false,"given":"Zhulin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1992-4556","authenticated-orcid":false,"given":"Sumit","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinph.2026.2112353_b0005","first-page":"235","article-title":"Influence of the surface EMG electrode on the compound muscle action potential","volume":"46","author":"Barkhaus","year":"2006","journal-title":"Electromyogr. Clin. Neurophysiol."},{"key":"10.1016\/j.clinph.2026.2112353_b0010","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.nmd.2023.02.004","article-title":"A new score combining compound muscle action potential (CMAP) amplitudes and motor score is predictive of motor outcome after AVXS-101 (Onasemnogene Abeparvovec) SMA therapy","volume":"33","author":"Barrois","year":"2023","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.clinph.2026.2112353_b0015","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70405","article-title":"Compound Muscle Action potential (CMAP) amplitude trajectories and pattern in adults with 5q-spinal muscular atrophy receiving nusinersen therapy: a multicenter, binational observational study","volume":"32","author":"Bjelica","year":"2025","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.clinph.2026.2112353_b0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fmolb.2016.00007","article-title":"Copy number variations in the survival motor neuron genes: implications for spinal muscular atrophy and other neurodegenerative diseases","volume":"3","author":"Butchbach","year":"2016","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.clinph.2026.2112353_b0030","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/jnnp.42.1.42","article-title":"Changes in motor unit populations in motor neurone disease","volume":"42","author":"Carleton","year":"1979","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.clinph.2026.2112353_b0035","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jpeds.2017.06.042","article-title":"Presymptomatic diagnosis of spinal muscular atrophy through newborn screening","volume":"190","author":"Chien","year":"2017","journal-title":"J. Pediatr."},{"key":"10.1016\/j.clinph.2026.2112353_b0040","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000200175","article-title":"Complex SMN hybrids detected in a cohort of 31 patients with spinal muscular atrophy","volume":"10","author":"Costa-Roger","year":"2024","journal-title":"Neurol Genet"},{"key":"10.1016\/j.clinph.2026.2112353_b0045","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1186\/s12887-022-03671-x","article-title":"Advances and limitations for the treatment of spinal muscular atrophy","volume":"22","author":"Day","year":"2022","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.clinph.2026.2112353_b0050","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ajmg.c.32003","article-title":"Georgia state spinal muscular atrophy newborn screening experience: screening assay performance and early clinical outcomes","volume":"190","author":"Elkins","year":"2022","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"10.1016\/j.clinph.2026.2112353_b0055","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.nmd.2015.04.009","article-title":"209th ENMC international workshop: outcome measures and clinical trial readiness in spinal muscular atrophy 7-9 November 2014, Heemskerk, The Netherlands","volume":"25","author":"Finkel","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.clinph.2026.2112353_b0060","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clinph.2026.2112353_b0065","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.nmd.2009.11.014","article-title":"The Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): test development and reliability","volume":"20","author":"Glanzman","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.clinph.2026.2112353_b0070","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/PEP.0b013e3182351f04","article-title":"Validation of the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND)","volume":"23","author":"Glanzman","year":"2011","journal-title":"Pediatr. Phys. Ther."},{"key":"10.1016\/j.clinph.2026.2112353_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/S0929-693X(20)30269-4","article-title":"Pathogenesis and therapeutic targets in spinal muscular atrophy (SMA)","volume":"27","author":"Lefebvre","year":"2020","journal-title":"Arch. Pediatr."},{"key":"10.1016\/j.clinph.2026.2112353_b0100","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/s12883-023-03420-2","article-title":"Changes in electrophysiological findings of spinal muscular atrophy type I after the administration of nusinersen and onasemnogene abeparvovec: two case reports","volume":"23","author":"Mizuno","year":"2023","journal-title":"BMC Neurol."},{"key":"10.1016\/j.clinph.2026.2112353_b0105","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.molmed.2024.12.006","article-title":"Pushing the boundaries: future directions in the management of spinal muscular atrophy","volume":"31","author":"Moultrie","year":"2025","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.clinph.2026.2112353_b0115","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.clinph.2018.04.614","article-title":"Implementing Motor Unit Number Index (MUNIX) in a large clinical trial: real world experience from 27 centres","volume":"129","author":"Neuwirth","year":"2018","journal-title":"Clin. Neurophysiol."},{"issue":"6","key":"10.1016\/j.clinph.2026.2112353_b0120","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/mus.70030","article-title":"Electrodiagnostic and functional biomarkers for non-ambulatory children with late-onset spinal muscular atrophy","volume":"72","author":"Ogata","year":"2025","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clinph.2026.2112353_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-med-070119-115459","article-title":"Gene-targeting therapeutics for neurological disease: lessons learned from spinal muscular atrophy","volume":"72","author":"Ravi","year":"2021","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.clinph.2026.2112353_b0135","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/s41591-022-01866-4","article-title":"Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the phase III SPR1NT trial","volume":"28","author":"Strauss","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.clinph.2026.2112353_b0140","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ana.20473","article-title":"Natural history of denervation in SMA: relation to age, SMN2 copy number, and function","volume":"57","author":"Swoboda","year":"2005","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.clinph.2026.2112353_b0145","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1093\/brain\/awaf123","article-title":"In utero therapy for spinal muscular atrophy: closer to clinical translation","volume":"148","author":"Tizzano","year":"2025","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.clinph.2026.2112353_b0150","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41436-020-00987-w","article-title":"CMAP changes upon symptom onset and during treatment in spinal muscular atrophy patients: lessons learned from newborn screening","volume":"23","author":"Weng","year":"2021","journal-title":"Genet. Med."}],"container-title":["Clinical Neurophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245726008539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245726008539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:42:09Z","timestamp":1788316929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388245726008539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":23,"alternative-id":["S1388245726008539"],"URL":"https:\/\/doi.org\/10.1016\/j.clinph.2026.2112353","relation":{},"ISSN":["1388-2457"],"issn-type":[{"value":"1388-2457","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Compound muscle action potential amplitudes in newborn screen positive spinal muscular atrophy","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinph.2026.2112353","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"2112353"}}